US HIV Study Should Be a Warning to Australia

Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.

US HIV Study Should Be a Warning to Australia

Australian Associated Press (12.19.01) - Thursday, December 20, 2001
Rada Rouse

A new study showing that three-quarters of Americans with HIV are resistant to one or more drugs should serve as a warning against complacency in Australia, an advocate said. Bill Whittaker, president of the Australian Federation for AIDS Organizations, said the findings followed a "wake-up call" for Australia earlier this year when it was revealed that the state of Victoria reported its first rise in new HIV infections for five years. "Some of these new infections are undoubtedly because people think they can just take the pills and they will be alright. People have to know there is no magic bullet, and we are seeing already an increasing trend in cross-resistance between the classes of drugs, as well as toxicity problems." Whittaker said the US study came at a time when Australian doctors were veering away from early treatment due to patients' problems with drug compliance and toxicity.
011220
AD012213

Copyright © 2001 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.